Pulmonary Fibrosis

Pulmonary Fibrosis Symptoms

Pulmonary fibrosis symptoms

Pulmonary Fibrosis Symptoms

The symptoms of pulmonary fibrosis can vary considerably from person to person. Some people experience a sudden onset of severe breathing difficulties, while others notice only minor discomfort that intensifies gradually over the course of several months or even years. In virtually all cases, however, the symptoms result from scar tissue that develops around the air sacs in the lungs (alveoli), which can make it increasingly difficult to breathe.

The most common pulmonary fibrosis symptoms are:

  • Shortness of breath (initially with physical activity and ultimately even at rest)
  • Fast, shallow breathing
  • Dry, hacking cough
  • Unexplained fatigue
  • Unintended weight loss
  • Muscle aches
  • Joint pain

Due to a lack of oxygen in the blood, some people with pulmonary fibrosis also notice that the tips of their fingers and toes begin to appear wide and rounded. Often referred to as clubbing, this symptom is caused by a thickening of the flesh underneath the fingernails and toenails, which causes the nails to curve downward.

Because there is currently no cure for pulmonary fibrosis, most treatments are aimed at relieving its symptoms. Traditional approaches include corticosteroids, immunotherapy, supplemental oxygen, pulmonary rehabilitation and, in very advanced cases, a lung transplant. The Lung Institute offers a groundbreaking alternative: stem cell therapy.

Stem cells are unique in that they are undifferentiated, which means that they can self-renew and become almost any type of cell in the body. By harnessing the regenerative power of stem cells taken from a patient’s own bone marrow or blood, this treatment can potentially stimulate healing and improve respiratory function. Stem cell therapy has freed many patients from the round-the-clock use of supplemental oxygen, allowing them to safely return to the activities they enjoy.

If you need help in managing your pulmonary fibrosis symptoms, you can confidently turn to the Lung Institute. We’re a world-recognized leader in regenerative medicine and stem cell research, and we specialize in autologous stem cell therapy for chronic lung conditions. For more information, contact us at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.